Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study

Background and purpose: In advanced ovarian cancer, delayed time to chemotherapy (TTC) has been associated with poorer survival outcomes; evidence is conflicting, however. This study investigated the impact of patient demographic factors on TTC and assessed whether TTC was associated with 5-year ove...

Full description

Bibliographic Details
Published in:	ESMO Real World Data and Digital Oncology
Main Authors:	L. Steventon, S. Nicum, K. Man, D. Dodwell, Z. Wang, A. Patel, B. Pickwell-Smith, L. Wei, P. Chambers
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	cancer ovarian surgery adjuvant chemotherapy treatment equity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949820125000323

Similar Items

Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Sergei Iugai, et al.
Published: (2025-04-01)

Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study
by: Yuan-Ting C. Lo, et al.
Published: (2023-04-01)

A Nomogram To Predict The Overall Survival Of Breast Cancer Patients And Guide The Postoperative Adjuvant Chemotherapy In China
by: Wang X, et al.
Published: (2019-11-01)

Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases
by: Sijian Li, et al.
Published: (2023-12-01)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
by: Shuogui Fang, et al.
Published: (2023-02-01)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
by: Alex Croese, et al.
Published: (2021-06-01)

The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
by: Masataka Shimonosono, et al.
Published: (2025-07-01)

Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay
by: Castillo C, et al.
Published: (2021-12-01)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
by: Irene Zarcos‐Pedrinaci, et al.
Published: (2019-11-01)

Feasibility and ability of laparoscopy to predict respectability in ovarian cancer: A cohort study
by: Mohammed Abdelrahman, et al.
Published: (2023-01-01)

Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2019-03-01)

Impact of adjuvant chemotherapy delay on overall survival in early-stage breast cancer: a retrospective analysis
by: Ahmad Alhalabi, et al.
Published: (2025-09-01)

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

The Effects of Different Induction Chemotherapy Cycles and Adjuvant Chemotherapy on the Survival Outcomes of Patients With Locally Advanced Nasopharyngeal Carcinoma
by: Shu Liao, et al.
Published: (2022-06-01)

Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study
by: Dian Liu, et al.
Published: (2024-03-01)

Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival
by: Jieun Kim, et al.
Published: (2021-06-01)

Impact of adjuvant chemotherapy on relapse-free survival of patients with locally advanced cervical cancer
by: M. P. Smirnova, et al.
Published: (2022-01-01)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01)

Epithelial ovarian cancer: Review article
by: Suchetha Sambasivan
Published: (2022-01-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer
by: Yuchong Yang, et al.
Published: (2023-05-01)

Survival outcomes and prognostic impact of adjuvant chemotherapy in stage IB lung adenocarcinoma with cribriform component
by: Rongyang Li, et al.
Published: (2025-07-01)

Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
by: Lin H, et al.
Published: (2021-07-01)

Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
by: Xingyu Liu, et al.
Published: (2023-06-01)

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
by: Shu Kato, et al.
Published: (2025-04-01)

A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma
by: Shinji Tsukamoto, et al.
Published: (2024-01-01)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
by: Visvikis A, et al.
Published: (2020-02-01)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
by: Pengfei Su, et al.
Published: (2023-10-01)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
by: Mao‐Chih Hsieh, et al.
Published: (2018-06-01)

Chemotherapy Associated Ovarian Failure
by: Davide Mauri, et al.
Published: (2020-12-01)

Interaction between glutathione S‐transferase M1‐null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer
by: Shuang Li, et al.
Published: (2018-09-01)

The Impact of Colon Cancer Sites on Survival Rates after Curative Resection and Adjuvant Chemotherapy: A SingleCenter Study
by: Sureerat Jaruhathai, et al.
Published: (2022-10-01)

The impact of RAD51 protein on the sensitivity of ovarian cancer to neoadjuvant chemotherapy
by: LIU Hui, CHEN Yunqing, QI Huiyang, SUN Xin, LOU Yanhui
Published: (2025-08-01)

Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II/III gastric cancer: a multicenter retrospective study
by: Zheng-Zheng Shen, et al.
Published: (2025-05-01)

Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis
by: Hariyono Winarto, et al.
Published: (2022-11-01)

Impact of delay in interval debulking surgery after neoadjuvant chemotherapy on survival in ovarian cancer
by: Kheyal Azam Khalil, et al.
Published: (2025-03-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)